Distributed by Abraxis BioScience, LLC
Bridgewater, NJ 08807

This Patient Information Leaflet has been approved by the U.S. Food and Drug Administration.

Based on: ABRAXANE Package Insert Revised: March 2010

Revised: March 2010

PRINCIPAL DISPLAY PANEL - 100 mg Vial
NDC 68817-134-50
103450

Abraxane®
for Injectable Suspension

(paclitaxel protein-bound particles for injectable suspension)
(albumin-bound)

100 mg
Single Use Vial

For IV Use Only
Rx only

Functional properties differ from other
paclitaxel products. DO NOT SUBSTITUTE.